FUNDACION PUBLICA ANDALUZA PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD - Spain 

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 1
Sole participant: 4
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 181.153 0 181.153 1
2022 0 6.348.927 0 1
2021 259.399 0 259.399 1
2018 328.243 0 328.243 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ANAXOMICS BIOTECH S L1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
BILKENT UNIVERSITESI1
BIOPREDIC INTERNATIONAL SARL1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
EMULATE INC1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PUERTA DE HIERROMAJADAHONDA1
HOSPITAL CLINIC DE BARCELONA1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
IZMIR BIYOTIP VE GENOM MERKEZI1
SERVICIO ANDALUZ DE SALUD1
SERVICIO CANTABRO DE SALUD1
SERVICIO MADRILENO DE SALUD1
THE UNIVERSITY OF EDINBURGH1
UNIVERSIDAD COMPLUTENSE DE MADRID1
UNIVERSIDAD DE MALAGA1
UNIVERSIDADE NOVA DE LISBOA1
UNIVERSITE DE RENNES I1
UNIVERSITY OF GLASGOW1

Constancy:

Total number of partners: 22
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 22
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2023-04-01Understanding the role of B cell phenotypes as a predictor of the efficacy and prognosis of allergen immunotherapy using allergic rhinitis to house dust mite as a model PRE-BITcoordinator181.1531
2022-12-01Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies halt-RONINparticipant6.348.92723
2021-09-10Development of a nanotechnology-based innovative assay for the diagnosis of allergy to Betalactams ASSERTcoordinator259.3991
2018-03-01Omics integration for precision cancer immunotherapy IMMUNOMARKcoordinator170.1221
2018-01-03Targeting the Endocannabinoid System within Islets of Langerhans to Protect against Immune Destruction. DIRECtAcoordinator158.1221